l-carnitine ctd Systemic primary carnitine deficiency Carnitine: Genetic Variants Affecting Mitochondrial

Levocarnitine tablets are also indicated for acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency

In a more recent study, fetuses from gilts supplemented with l-carnitine were heavier, had lower IGF-1 mRNA concentrations in the liver and lower IGF-II concentrations in plasma at day 70 of gestation compared with fetus of control gilts ( Reference Brown, Goodband and Tokach 47 )

Addressing these metabolic demands, L-carnitine (LC), a compound involved in fatty acid oxidation, has been proposed as a promising ergogenic aid

doi:10.1164/ajrccm.157.5.9709032 Viniol C, Vogelmeier CF